The US Food and Drug Administration has imposed a ban on a company offering personal genetic screening to the general public Googlebacked andme has been ordered to immediately discontinue selling its salivacollection tests after failing to provide information to back its marketing claims The tests aims to show how personal genetic codes may affect future health The company said it would address concerns The startup has been operating since  and was cofounded by Anne Wojcicki the wife of Google cofounder Sergey Brin For   users receive a kit allowing them to take sample of saliva  This is sent to the company and in return users receive a readout of their genetic code  The website promises reports on  health conditions and traits as well as offering to help people trace their genealogy Under FDA rules the company must provide proof about how accurate its detection methods are as well as supplying the error rates from its personal genome service PGS In a   the FDA said that andme had not supplied this information despite increasing its marketing campaign and the scope of its tests FDA is concerned about the public health consequences of inaccurate results from the PGS device  the main purpose of compliance with FDAs regulatory requirements is to ensure that the tests work said Alberto Gutierrez director of the FDAs centre for devices and radiological health in a letter to the company Patients relying on such tests may begin to selfmanage their treatment through dose changes or even abandon certain therapies depending on the outcome of the assessment he added Despite hundreds of emails and  facetoface meetings with andme little evidence had been provided the agency added The company said We recognise that we have not met the FDAs expectations regarding timeline and communication regarding our submission Our relationship with the FDA is extremely important to us and we are committed to fully engaging with them to address their concerns  The Center for Genetics and Society said it welcomed the FDAs stance Our society regulates medical products to protect public health Without strong public oversight were back to the era of snake oil said executive director Marcy Darnovsky The public agency charged with protecting public health has finally lost patience with a private company that seems to think it doesnt have to play by the rules she added It is not the first time the company has hit the headlines A buildababy patent which offered to show perspective parents what traits a future baby may have was criticised by the Genetics and Society organisation The company described the system as an enjoyable way for parents to dip their toes into genetics There are an increasing number of companies offering lowcost home genetic testing  but some medical experts have raised questions about the accuracy of the tests and asked what benefit they offer to consumers